Edesa Biotech Inc <EDSA.OQ> expected to post a loss of 31 cents a share - Earnings Preview

• Edesa Biotech Inc EDSA.OQ EDSA.O is expected to show no change in quarterly revenue when it reports results on February 17 (estimated) for the period ending December 31 2024

• ​LSEG's mean analyst estimate for Edesa Biotech Inc is for a loss of 31 cents per share.

• The one available analyst rating on the shares is "buy".

• The mean earnings estimate of analysts was unchanged in the last three months. ​

• Wall Street's median 12-month price target for Edesa Biotech Inc is $20.50​, above​ its last closing price of $3.25. ​​​

This summary was machine generated February 14 at 11:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)